North Wales, PA, United States of America

Umar S M Maharoof



Average Co-Inventor Count = 5.5

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2010-2012

Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: Innovations of Umar S M Maharoof

Introduction

Umar S M Maharoof is an accomplished inventor based in North Wales, PA (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that target diseases associated with γ-secretase activity, including Alzheimer's disease. With a total of 3 patents, his work has the potential to impact the treatment of neurodegenerative disorders.

Latest Patents

Umar's latest patents include innovative compounds designed to modulate γ-secretase activity. The first patent, titled "Piperidinyl and piperazinyl modulators of γ-secretase," relates to compounds of Formula I, which are defined in the specification. These compounds are particularly useful for treating diseases linked to γ-secretase activity, such as Alzheimer's disease. The second patent, "Amine linked modulators of γ-secretase," also focuses on compounds of Formula I, with definitions provided in the specification. Similar to the first, these compounds aim to address diseases associated with γ-secretase activity.

Career Highlights

Throughout his career, Umar has worked with notable companies in the pharmaceutical industry. He has been associated with Janssen Pharmaceutica and Cellzome Limited, where he contributed to research and development efforts aimed at advancing medical treatments.

Collaborations

Umar has collaborated with esteemed colleagues, including Chih Yung Ho and Yan Zhang. Their combined expertise has likely enhanced the quality and impact of their research endeavors.

Conclusion

Umar S M Maharoof is a notable inventor whose work in developing γ-secretase modulators holds promise for treating Alzheimer's disease. His contributions to the pharmaceutical field reflect a commitment to innovation and improving patient outcomes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…